Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study.

Noemí Cerulla TorrenteÀngels ArcusaJosé-Blas NavarroMaite GaroleraCristina EneroGlòria ChicoLuís Fernández-Morales

Published in: Breast cancer research and treatment (2017)

Our results suggest that chemotherapy for BC with a FEC regimen can have a negative effect on cognition. Acute deficits seem to be larger when taxanes are added, but treatment seems to affect cognition also at long term.

Keyphrases

cognitive impairment
locally advanced
mild cognitive impairment
liver failure
white matter
traumatic brain injury
respiratory failure
radiation therapy
rectal cancer
chemotherapy induced
combination therapy